Putnam Global Health Care FundPHSBX
Type
Mutual fund
Peer group
Global equity
Net assets
$1.6B
Expense ratio
—
1-year return
+26.0%
3 years, a year
+8.0%
5 years, a year
+14.1%
Holdings
119
What it aims to do.
The fund seeks capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co. | 11.34% |
| JNJ Johnson & Johnson | 8.91% |
| ABBV AbbVie, Inc. | 5.94% |
| Novartis AG | 5.53% |
| MRK Merck & Co., Inc. | 5.33% |
| AstraZeneca plc | 5.04% |
| UNH UnitedHealth Group, Inc. | 4.92% |
| ISRG Intuitive Surgical, Inc. | 3.90% |
| TMO Thermo Fisher Scientific, Inc. | 3.70% |
| Roche Holding AG | 2.91% |
More on PHSBX.
- PHSBX overview
- PHSBX holdings
- PHSBX risk
- PHSBX costs
- PHSBX money in and out
- PHSBX share classes
- Compare PHSBX with other funds
Returns after fees, from the fund's SEC filings up to Aug 2024. Past returns are not a promise. Not financial advice.